Cargando…

Characterization of potent RSV neutralizing antibodies isolated from human memory B cells and identification of diverse RSV/hMPV cross-neutralizing epitopes

Respiratory syncytial virus (RSV) is a leading cause of lower respiratory tract infection in young children and older adults. Currently, no licensed vaccine is available, and therapeutic options are limited. The primary target of neutralizing antibodies to RSV is the surface fusion (F) glycoprotein....

Descripción completa

Detalles Bibliográficos
Autores principales:	Xiao, Xiao, Tang, Aimin, Cox, Kara S., Wen, Zhiyun, Callahan, Cheryl, Sullivan, Nicole L., Nahas, Deborah D., Cosmi, Scott, Galli, Jennifer D., Minnier, Michael, Verma, Deeptak, Babaoglu, Kerim, Su, Hua, Bett, Andrew J., Vora, Kalpit A., Chen, Zhifeng, Zhang, Lan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2019
Materias:	Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6816417/ https://www.ncbi.nlm.nih.gov/pubmed/31402751 http://dx.doi.org/10.1080/19420862.2019.1654304

Ejemplares similares

Profiling of hMPV F-specific antibodies isolated from human memory B cells
por: Xiao, Xiao, et al.
Publicado: (2022)

Innate Immune Components That Regulate the Pathogenesis and Resolution of hRSV and hMPV Infections
por: Andrade, Catalina A., et al.
Publicado: (2020)

A Chimeric Pneumovirus Fusion Protein Carrying Neutralizing Epitopes of Both MPV and RSV
por: Wen, Xiaolin, et al.
Publicado: (2016)

117. Effect of Nasopharyngeal Pneumococcal Carriage on RSV and hMPV Illness Severity in Infants in Nepal
por: Murray, Alastair, et al.
Publicado: (2018)

Discovery and Characterization of Phage Display-Derived Human Monoclonal Antibodies against RSV F Glycoprotein
por: Chen, Zhifeng, et al.
Publicado: (2016)

Non-Coding RNAs and Their Role in Respiratory Syncytial Virus (RSV) and Human Metapneumovirus (hMPV) Infections
por: Wu, Wenzhe, et al.
Publicado: (2020)

COPD Is Associated with Elevated IFN-β Production by Bronchial Epithelial Cells Infected with RSV or hMPV
por: Collinson, Natasha, et al.
Publicado: (2021)

1644. A Potent Broadly Neutralizing Antibody Isolated From Human Memory B-cells Binding to Conserved Site IV on the RSV F Protein
por: Vora, Kalpit, et al.
Publicado: (2018)

A potent broadly neutralizing human RSV antibody targets conserved site IV of the fusion glycoprotein
por: Tang, Aimin, et al.
Publicado: (2019)

Infant Pneumococcal Carriage During Influenza, RSV, and hMPV Respiratory Illness Within a Maternal Influenza Immunization Trial
por: Murray, Alastair F, et al.
Publicado: (2019)

2085. Evaluation of Panther Fusion Flu A/B/RSV, AdV/hMPV/RV and Paraflu Assays for the Detection of Respiratory Viruses in Children
por: Hassan, Ferdaus, et al.
Publicado: (2018)

hMPV Lineage Nomenclature and Heparin Binding
por: Adamson, Penelope, et al.
Publicado: (2013)

Prevalent levels of RSV serum neutralizing antibodies in healthy adults outside the RSV-season
por: Van Der Plas, Johan L., et al.
Publicado: (2019)

Molecular epidemiology of human metapneumovirus (hMPV) in Cambodia
por: Arnott, Alicia, et al.
Publicado: (2011)

Host Components That Modulate the Disease Caused by hMPV
por: Gálvez, Nicolás M. S., et al.
Publicado: (2021)

Respiratory Infections by HMPV and RSV Are Clinically Indistinguishable but Induce Different Host Response in Aged Individuals
por: Ditt, Vanessa, et al.
Publicado: (2011)

RSV A2-Based Prefusion F Vaccine Candidates Induce RSV A and RSV B Cross Binding and Neutralizing Antibodies and Provide Protection against RSV A and RSV B Challenge in Preclinical Models
por: Cox, Freek, et al.
Publicado: (2023)

Human Metapneumovirus (hMPV) Infection and MPV467 Treatment in Immunocompromised Cotton Rats Sigmodon hispidus
por: Yim, Kevin C., et al.
Publicado: (2023)

The importance of RSV F protein conformation in VLPs in stimulation of neutralizing antibody titers in mice previously infected with RSV
por: Cullen, Lori M., et al.
Publicado: (2017)

Durability of neutralizing RSV antibodies following nirsevimab administration and elicitation of the natural immune response to RSV infection in infants
por: Wilkins, Deidre, et al.
Publicado: (2023)

RSV and HMPV seroprevalence in Tuscany (Italy) and North‐Rhine Westfalia (Germany) in the winter season 2009/2010
por: Cusi, Maria G., et al.
Publicado: (2011)

Diversity in Glycosaminoglycan Binding Amongst hMPV G Protein Lineages
por: Adamson, Penelope, et al.
Publicado: (2012)

Adult human metapneumonovirus (hMPV) pneumonia mimicking Legionnaire's disease
por: Cunha, Burke A., et al.
Publicado: (2016)

Forward and reverse translational approaches to predict efficacy of neutralizing respiratory syncytial virus (RSV) antibody prophylaxis
por: Maas, Brian M., et al.
Publicado: (2021)

RSV and HMPV Infections in 3D Tissue Cultures: Mechanisms Involved in Virus-Host and Virus-Virus Interactions
por: Geiser, Johan, et al.
Publicado: (2021)

Flexible RSV Prefusogenic Fusion Glycoprotein Exposes Multiple Neutralizing Epitopes that May Collectively Contribute to Protective Immunity
por: Patel, Nita, et al.
Publicado: (2020)

Pre-fusion RSV F strongly boosts pre-fusion specific neutralizing responses in cattle pre-exposed to bovine RSV
por: Steff, Ann-Muriel, et al.
Publicado: (2017)

Time series non-Gaussian Bayesian bivariate model applied to data on HMPV and RSV: a case of Dadaab in Kenya
por: Nyoka, Raymond, et al.
Publicado: (2019)

Respiratory Syncytial Virus (RSV) Neutralizing Antibodies at Birth Predict Protection from RSV Illness in Infants in the First 3 Months of Life
por: Buchwald, Andrea G, et al.
Publicado: (2020)

998. Forward and Reverse Translational Approaches to Predict Efficacy of the Neutralizing Respiratory Syncytial Virus (RSV) Antibody MK-1654
por: Maas, Brian M, et al.
Publicado: (2021)

Is it RSV?
por: Ambrose, Christopher S.
Publicado: (2018)

1971. A Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Safety and Tolerability of a Respiratory Syncytial Virus (RSV) Neutralizing Monoclonal Antibody (MK-1654) in Healthy Subjects
por: Aliprantis, Antonios, et al.
Publicado: (2018)

A human antibody potently neutralizes RSV by targeting the conserved hydrophobic region of prefusion F
por: Yi, Chunyan, et al.
Publicado: (2023)

2630. Treatment of RSV Lower Respiratory Tract Infection in Two Immunocompromised Children with Polyclonal Immunoglobulin Containing Standardized Levels of Neutralizing Anti-RSV Antibody
por: Levy, Emily Ruth, et al.
Publicado: (2019)

Human Metapneumovirus (hMPV) in Acute Respiratory Infection: A Clinic-Based Study in Egypt
por: Yahia, Sohier, et al.
Publicado: (2012)

Epitope-Specific Serological Assays for RSV: Conformation Matters
por: Phung, Emily, et al.
Publicado: (2019)

Structural basis for recognition of the central conserved region of RSV G by neutralizing human antibodies
por: Jones, Harrison G., et al.
Publicado: (2018)

2781. Statistical Modeling to Predict Maternal RSV Vaccine Efficacy from Neutralizing Titers
por: Cai, Bing, et al.
Publicado: (2019)

Motavizumab, A Neutralizing Anti-Respiratory Syncytial Virus (Rsv) Monoclonal Antibody Significantly Modifies The Local And Systemic Cytokine Responses Induced By Rsv In The Mouse Model
por: Mejías, Asunción, et al.
Publicado: (2007)

Binding and Neutralizing Capacity of Respiratory Syncytial Virus (RSV)-Specific Recombinant IgG Against RSV in Human Milk, Gastric and Intestinal Fluids from Infants
por: Demers-Mathieu, Veronique, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_hnn2eocg7r4asuod73grai0pu9